| Income Statement for Panacos Pharmaceuticals Inc. (PANC) | | | | | | | Income | in Thousands of Dollars | | | 12/2007 | 12/2006 | 12/2005 | 12/2004 | 12/2003 | | | Operating Revenue | 180 | 284 | 1,049 | 1,682 | 716 | | Adjustments to Revenue | - | - | - | - | - | | Cost of Revenue | 794 | 751 | 629 | 974 | 1,061 | | Gross Operating Profit | 974 | 1,035 | 1,678 | 2,656 | 1,777 | | | Selling/General/Admin Expense | (12,840) | (17,431) | (8,045) | (6,456) | (4,335) | | Research & Development | (25,090) | (24,548) | (19,798) | (13,289) | (18,508) | | EBITDA | (36,956) | (40,944) | (26,165) | (17,090) | (21,065) | | Depreciation & Amortization | (794) | (751) | (629) | (974) | (1,061) | | EBIT | (37,750) | (41,695) | (26,794) | (18,063) | (22,126) | | Interest Income | 2,705 | 3,591 | 912 | - | (227) | | Other Income, Net | (15) | (6) | (6) | - | - | | Total Income Avail For Interest Expense | (36,332) | (38,110) | (59,078) | (18,063) | (22,353) | | Interest Expense | (1,127) | - | - | (99) | - | | Pre-Tax Income | (37,459) | (38,110) | (59,078) | (18,162) | (22,353) | | Income Taxes | - | - | - | - | - | | Minority Interest | - | - | - | - | - | | Net Income from Continuing Operations | (37,459) | (38,110) | (59,078) | (18,162) | (22,353) | | Net Income from Discontinued Operations | - | - | - | - | - | | Net Income from Total Operations | (37,459) | (38,110) | (59,078) | (18,162) | (22,353) | | | Normalized Income | (36,187) | (38,110) | (25,888) | (18,162) | (22,353) | | Extraordinary Income | - | - | - | - | - | | Special Income/Charges | (1,272) | - | (33,190) | - | - | | Income from Cum. Effect of Acct Change | - | - | - | - | - | | Income from Tax Loss Carryforward | - | - | - | - | - | | Other Gains | - | - | - | - | - | | Total Net Income | (37,459) | (38,110) | (59,078) | (18,162) | (22,353) | | | Results | in Dollars (Preferred Dividends in Thousands) | | | 12/2007 | 12/2006 | 12/2005 | 12/2004 | 12/2003 | | | Dividends Paid Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | | Preferred Dividends | - | - | - | - | - | | | Basic EPS from Continuing Operations | -0.70 | -0.75 | -1.72 | -3.50 | -6.70 | | Basic EPS from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | | Basic EPS from Total Operations | -0.70 | -0.75 | -1.72 | -3.50 | -6.70 | | | Diluted EPS from Continuing Operations | -0.70 | -0.75 | -1.72 | -3.50 | -6.70 | | Diluted EPS from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | | Diluted EPS from Total Operations | -0.70 | -0.75 | -1.72 | -3.50 | -6.70 | | | |
